| Literature DB >> 24655431 |
Carla Maia1, Cláudia Ramos, Mónica Coimbra, Filipa Bastos, Angela Martins, Pedro Pinto, Mónica Nunes, Maria Luísa Vieira, Luís Cardoso, Lenea Campino.
Abstract
BACKGROUND: Feline vector-borne diseases (FVBD) have emerged in recent years, showing a wider geographic distribution and increased global prevalence. In addition to their veterinary importance, domestic cats play a central role in the transmission cycles of some FVBD agents by acting as reservoirs and sentinels, a circumstance that requires a One Health approach. The aim of the present work was to molecularly detect feline vector-borne bacteria and protozoa with veterinary and zoonotic importance, and to assess associated risk factors in cats from southern Portugal.Entities:
Mesh:
Year: 2014 PMID: 24655431 PMCID: PMC3972989 DOI: 10.1186/1756-3305-7-115
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Comparison of prevalence of FVBD pathogens in different groups of cats from southern Portugal
| 649 | | | | | | | | |
| Female | 372 (57.3) | 18 (4.8) | 31 (8.3) | 11 (3.0) | 9 (2.4) | 32 (8.6) | 44 (11.8) | 122 (32.8) |
| Male | 277 (42.7) | 17 (6.1) | 12 (4.3) | 8 (2.9) | 5 (1.8) | 24 (8.7) | 20 (7.2) | 72 (26.0) |
| 484 | | | | | | | | |
| DSH | 432 (89.3) | 22 (5.1) | 22 (5.1)* | 10 (2.3) | 4 (0.9) | 31 (7.2) | 33 (7.6) | 109 (25.2) |
| Other breed | 52 (10.7) | 1 (1.9) | 10 (19.2)* | 2 (3.8) | 1 (1.9) | 3 (5.8) | 7 (13.5) | 19 (36.5) |
| 649 | | | | | | | | |
| Domestic | 320 (49.3) | 9 (2.8)* | 28 (8.8)* | 5 (1.6) | 3 (0.9) | 24 (7.5) | 33 (10.3) | 91 (28.4) |
| Stray | 329 (50.7) | 26 (7.9)* | 15 (4.6)* | 14 (4.3) | 11 (3.3) | 32 (9.7) | 31 (9.4) | 103 (31.3) |
| 462 | | | | | | | | |
| [3-11] | 129 (27.9) | 5 (3.9) | 13 (10.1) | 4 (3.1) | 1 (0.8) | 3 (2.3)* | 6 (4.7)a | 27 (20.9) |
| [12-59] | 216 (46.8) | 10 (4.6) | 13 (6.0) | 6 (2.8) | 0 (0.0) | 17 (7.9) | 14 (6.5)b | 54 (25.0) |
| [60-228] | 117 (25.3) | 5 (4.3) | 5 (4.3) | 0 (0.0) | 2 (1.7) | 11 (9.4)* | 16 (13.7)a,b | 35 (29.9) |
| 568 | | | | | | | | |
| Yes | 204 (35.9) | 5 (2.5) | 4 (2.0)* | 3 (1.5) | 3 (1.5) | 11 (5.4)* | 27 (13.2)* | 51 (25.0)* |
| No | 364 (64.1) | 22 (6.0) | 37 (10.2)* | 16 (4.4) | 10 (2.7) | 42 (11.5)* | 28 (7.7)* | 126 (34.6)* |
| 649 | | | | | | | | |
| Lisbon | 386 (59.5) | 18 (4.7) | 9 (2.3)* | 8 (2.1) | 3 (0.8)* | 25 (6.5)* | 31 (8.0) | 85 (22.0)* |
| Algarve | 263 (40.5) | 17 (6.5) | 34 (12.9)* | 11 (4.2) | 11 (4.2)* | 31 (11.8)* | 33 (12.5) | 109 (41.4)* |
| 649 | | | | | | | | |
| Urban | 282 (43.5) | 18 (6.4) | 8 (2.8)* | 4 (1.4) | 0 (0.0) | 14 (5.0)* | 9 (3.2)* | 47 (16.7)* |
| Rural | 367 (56.5) | 17 (4.6) | 35 (9.5)* | 15 (4.1) | 14 (3.8) | 42 (11.4)* | 55 (15.0)* | 147 (40.1)* |
| 589 | | | | | | | | |
| Totally indoors | 124 (21.1) | 3 (2.4) | 6 (4.8) | 1 (0.8) | 0 (0.0) | 3 (2.4)* | 13 (10.5) | 24 (19.4)* |
| Access to outdoors | 465 (78.9) | 28 (6.0) | 36 (7.7) | 17 (3.7) | 8 (1.7) | 51 (11.0)* | 39 (8.4) | 151 (32.5)* |
| 242 | | | | | | | | |
| Negative | 231 (95.5) | 12 (5.2) | 15 (6.5) | 6 (2.6) | 6 (2.6) | 13 (5.6) | 29 (12.6) | 70 (30.3) |
| Positive | 11 (4.5) | 1 (9.1) | 1 (9.1) | 0 (0.0) | 1 (9.1) | 1 (9.1) | 0 (0.0) | 3 (27.3) |
| 247 | | | | | | | | |
| Negative | 226 (91.5) | 11 (4.9) | 16 (7.1) | 6 (2.7) | 6 (2.7) | 14 (6.2) | 28 (12.4) | 69 (30.5) |
| Positive | 21 (8.5) | 3 (14.3) | 1 (4.8) | 0 (0.0) | 1 (4.8) | 1 (4.8) | 1 (4.8) | 6 (28.6) |
| 222 | | | | | | | | |
| Non-suspect | 197 (88.7) | 8 (4.1) | 26 (13.2) | 1 (0.5) | 0 (0.0) | 12 (6.1) | 8 (4.1) | 49 (24.9) |
| Suspect | 25 (11.3) | 3 (12.0) | 1 (4.0) | 0 (0.0) | 0 (0.0) | 1 (4.0) | 3 (12.0) | 6 (24.0) |
| 649 (100) | 35 (5.4) | 43 (6.6) | 19 (2.9) | 14 (2.2) | 56 (8.6) | 64 (9.9) | 194 (29.9) | |
*,a,b Statistically significant difference (p <0.05); DSH: domestic short-haired; FeLV: feline leukaemia virus; FIV: feline immunodeficiency virus.
Primer sets for PCR amplification of FVBD agents
| 16S rRNA | EHR16SD: 5′-GGT ACC YAC AGA AGA AGTCC-3′ | 345 | 95°C, 5 min; 35 cycles [94°C 30 sec, 55°C 30 sec, 72°C 90 sec]; 72°C, 5 min | [ | |
| | EHR16SR: 5′-TAG CAC TCA TCG TTT ACAGC-3′ | ||||
| 18S rRNA | PIRO-A: 5′-AAT ACC CAA TCC TGA CACAGG G-3′ | 400 | 95°C, 5 min; 35 cycles [94°C 30 sec, 55°C 30 sec, 72°C 90 sec]; 72°C, 5 min | [ | |
| | PIRO-B: 5′-TTA AAT ACG AAT GCC CCCAAC-3′ | ||||
| 16S-23S rRNA | 325 s: 5′-CTTCAGATGATGATCCCAAGCCTTCTGGCG-3′ | 500-800 | 95°C, 5 min; 55 cycles [95°C 15 sec, 66°C 15 sec, 72°C 15 sec]; 72°C, 1 min | [ | |
| | 1100as: 5′-GAACCGACGACCCCCTGCTTGCAAAGCA-3′ | ||||
| 5S-23S rRNA | Outer primers: | 380 | | [ | |
| | 23SN1: 5′-ACCATAGACTCTTATTACTTTGAC-3′ | 94.5°C, 1 min; 25 cycles [94°C 30 sec, 52°C 30 sec, 72°C 1 min]; 72°C, 5 min | |||
| | 23SC1: 5′-TAAGCTGACTAATACTAATTACCC-3′ | ||||
| | Inner primers: | 225 | | ||
| | 23SN2: 5′-ACCATAGACTCTTATTACTTTGACCA-3′ | 94.5°C, 1 min; 40 cycles [94°C 30 sec, 55°C 30 sec, 72°C 1 min]; 72°C, 5 min | |||
| | 5SCB: 5′-biotin-GAGAGTAGGTTATTGCCAGGG-3′ | ||||
| 18S rRNA | HEP-F: 5′-ATA CAT GAG CAA AAT CTC AAC-3′ | 626-666 | 95 °C, 5 min; 34 cycles [95 °C 20 sec, 55 °C, 30 sec, 72 °C, 90 sec]; 72 °C, 5 min | [ | |
| | HEP-R: 5′-CTT ATT ATT CCA TGC TGC AG-3′ | ||||
| Small subunit rRNA | Outer primers: | 603 | | [ | |
| | R221: 5′-GGTTCCTTTCCTGATTTACG-3′ | 94°C, 5 min; 35 cycles [94°C 30 sec, 60°C 30 sec, 72°C 30 sec]; 72°C, 10 min | |||
| | R332: 5′-GGCCGGTAAAGGCCGAATAG-3′ | ||||
| | Inner primers: | 358 | | [ | |
| | R223: 5′-TCCCATCGCAACCTCGGTT-3′ | 94°C, 5 min; 35 cycles [94°C 30 sec, 65°C 30 sec, 72°C 30 sec]; 72°C, 10 min | |||
| R333: 5′-AAAGCGGGCGCGGTGCTG-3′ |
Single and mixed PCR-positivity to genera ( / , , , and ) and/or complex ( s.l.) of FVBD agents in 649 cats from southern Portugal
| Single positivity | 161 (24.8) |
| 24 (3.7) | |
| 28 (4.3) | |
| 10 (1.5) | |
| 8 (1.2) | |
| 37 (5.7) | |
| 54 (8.3) | |
| Mixed positivity | 33 (5.1) |
| 2 (0.3) | |
| 1 (0.2) | |
| 2 (0.3) | |
| 2 (0.3) | |
| 3 (0.5) | |
| 8 (1.2) | |
| 2 (0.3) | |
| 1 (0.2) | |
| 2 (0.3) | |
| 1 (0.2) | |
| 3 (0.5) | |
| 2 (0.3) | |
| 2 (0.3) | |
| 1 (0.2) | |
| 1 (0.2) | |
| Total | 194 (29.9) |